Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent

  • Marc Tischkowitz1, 2, 3, 10Email author,
  • Nelly Sabbaghian1, 2,
  • Nancy Hamel4,
  • Carly Pouchet5,
  • William D Foulkes1, 2, 4, 5,
  • Anne-Marie Mes-Masson6, 7,
  • Diane M Provencher6, 8 and
  • Patricia N Tonin1, 4, 9
BMC Medical Genetics201314:5

https://doi.org/10.1186/1471-2350-14-5

Received: 10 September 2012

Accepted: 3 January 2013

Published: 9 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
10 Sep 2012 Submitted Original manuscript
22 Oct 2012 Reviewed Reviewer Report - Christos Kroupis
6 Nov 2012 Reviewed Reviewer Report - Claudia Vitoria De Moura Gallo
26 Nov 2012 Author responded Author comments - Marc Tischkowitz
Resubmission - Version 2
26 Nov 2012 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Nov 2012 Reviewed Reviewer Report - Christos Kroupis
3 Dec 2012 Reviewed Reviewer Report - Claudia Vitoria De Moura Gallo
17 Dec 2012 Author responded Author comments - Marc Tischkowitz
Resubmission - Version 4
17 Dec 2012 Submitted Manuscript version 4
Publishing
3 Jan 2013 Editorially accepted
9 Jan 2013 Article published 10.1186/1471-2350-14-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University
(2)
Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital
(3)
Department of Medical Genetics, University of Cambridge
(4)
The Research Institute of the McGill University Health Centre
(5)
Department of Medical Genetics, Jewish General Hospital
(6)
Centre de recherche du Centre hospitalier de l′Université de Montréal (CRCHUM)/Institut du cancer de Montréal
(7)
Département de médicine, Université de Montréal
(8)
Division de gynécologie oncologique, et Département d’obstétrique et gynécologie, Université de Montréal
(9)
Department of Medicine, McGill University
(10)
Department of Medical Genetics, Addenbrooke’s Treatment Centre, Addenbrooke's Hospital, University of Cambridge

Advertisement